HOOKIPA Pharma Inc.

NASDAQ: HOOK · Real-Time Price · USD
1.57
-0.02 (-1.26%)
At close: Jun 02, 2025, 3:59 PM
1.60
1.91%
After-hours: Jun 02, 2025, 07:38 PM EDT

HOOKIPA Pharma Statistics

Share Statistics

HOOKIPA Pharma has 12.19M shares outstanding. The number of shares has increased by -87.51% in one year.

Shares Outstanding 12.19M
Shares Change (YoY) -87.51%
Shares Change (QoQ) 24.9%
Owned by Institutions (%) 42.51%
Shares Floating n/a
Failed to Deliver (FTD) Shares 87
FTD / Avg. Volume 0.08%

Short Selling Information

The latest short interest is 188.54K, so 1.55% of the outstanding shares have been sold short.

Short Interest 188.54K
Short % of Shares Out 1.55%
Short % of Float 2.38%
Short Ratio (days to cover) 1

Valuation Ratios

The PE ratio is -0.58 and the forward PE ratio is -0.74. HOOKIPA Pharma's PEG ratio is 0.01.

PE Ratio -0.58
Forward PE -0.74
PS Ratio 0.57
Forward PS 1
PB Ratio 0.49
P/FCF Ratio -0.33
PEG Ratio 0.01
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for HOOKIPA Pharma.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.27, with a Debt / Equity ratio of 0.02.

Current Ratio 3.27
Quick Ratio 3.27
Debt / Equity 0.02
Debt / EBITDA -0.02
Debt / FCF -0.01
Interest Coverage -25727.5

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $535,926.83
Profits Per Employee $-530,524.39
Employee Count 82
Asset Turnover 0.53
Inventory Turnover n/a

Taxes

Income Tax -106K
Effective Tax Rate 0.24%

Stock Price Statistics

The stock price has increased by -81.93% in the last 52 weeks. The beta is 0.95, so HOOKIPA Pharma's price volatility has been higher than the market average.

Beta 0.95
52-Week Price Change -81.93%
50-Day Moving Average 1.17
200-Day Moving Average 2.54
Relative Strength Index (RSI) 58.11
Average Volume (20 Days) 115,295

Income Statement

In the last 12 months, HOOKIPA Pharma had revenue of 43.95M and earned -43.5M in profits. Earnings per share was -3.47.

Revenue 43.95M
Gross Profit 43.95M
Operating Income -51.45M
Net Income -43.5M
EBITDA -40.85M
EBIT -43.61M
Earnings Per Share (EPS) -3.47
Full Income Statement

Balance Sheet

The company has 39.68M in cash and 875K in debt, giving a net cash position of 38.81M.

Cash & Cash Equivalents 39.68M
Total Debt 875K
Net Cash 38.81M
Retained Earnings -412.76M
Total Assets 61.26M
Working Capital 43.45M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -76.98M and capital expenditures -194K, giving a free cash flow of -77.17M.

Operating Cash Flow -76.98M
Capital Expenditures -194K
Free Cash Flow -77.17M
FCF Per Share -6.15
Full Cash Flow Statement

Margins

Gross margin is 100%, with operating and profit margins of -117.09% and -98.99%.

Gross Margin 100%
Operating Margin -117.09%
Pretax Margin -99.23%
Profit Margin -98.99%
EBITDA Margin -92.96%
EBIT Margin -117.09%
FCF Margin -175.61%

Dividends & Yields

HOOK does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for HOOK is $4.5, which is 186.6% higher than the current price. The consensus rating is "Hold".

Price Target $4.5
Price Target Difference 186.6%
Analyst Consensus Hold
Analyst Count 3
Stock Forecasts

Stock Splits

The last stock split was on Jul 10, 2024. It was a backward split with a ratio of 1:10.

Last Split Date Jul 10, 2024
Split Type backward
Split Ratio 1:10

Scores

Altman Z-Score -12.51
Piotroski F-Score 2